What is the Economic Value of an AI Tool for the Triage of Skin Cancer in the UK?

You may also be interested in

Peer-reviewed publication

Comparing Statistically Reliable and Patient-Perceived Improvement Following Hip Arthroplasty: Rasch-Based and Anchor-Based Approaches

YHEC authors: Adam Smith, Damian Lewis, Stuart Mealing, Andria Joseph

Publication date: September 2026

Journal: Journal of Patient Reported Outcomes

Abstract

BACKGROUND: Interpreting meaningful change in patient-reported outcome measures (PROMs) is essential for assessing hip replacement outcomes. The Oxford Hip Score (OHS) is widely used, yet statistically detectable change may not...

Peer-reviewed publication

Mitigating Bias in Health-Related Quality of Life (HRQoL) Estimation Due to Missing Data: A Simulation-Based Study Evaluating Imputation Methods

YHEC authors: Joe Moss, Neil Hansell, Erin Barker, Matthew Taylor

Publication date: August 2026

Publishers: MDPI

Journal: Health Economics & Policy

Abstract

Missing Health-Related Quality of Life (HRQoL) data in clinical studies risk propagating bias into health technology assessments (HTAs) and cost-utility analyses. Despite this, current National Institute for Health and Care...

Peer-reviewed publication

Cost-Effectiveness of Maternal RSVpreF Vaccination Compared with Newborn Nirsevimab RSV Prophylaxis or No RSV Prophylaxis in Switzerland

YHEC authors: Amy Dymond, Stuart Mealing, Charlotte Graham

Publication date: August 2026

Journal: Applied Health Economics and Health Policy

Abstract

BACKGROUND: RSVpreF is a vaccine that immunises against respiratory syncytial virus (RSV), a seasonal respiratory virus, that can lead to lower respiratory tract infections. In Switzerland, RSVpreF is indicated for...